HIGHLIGHTS
- who: Mitochondrial-Targeted Antioxidant Peptide SS and colleagues from the Department of Ophthalmology, The Second Affiliated Hospital of Medical University, China have published the research work: Mitochondrial-Targeted Antioxidant Peptide SS31 Prevents RPE Cell Death under Oxidative Stress, in the Journal: BioMed Research International of 27/05/2022
- what: In this experiment, SS31 was shown to reduce the release level of ROS in ARPE-19 cells under OS. In the experiment , the protective actions of SS31 on ARPE19 cells under OS were reported, which showed a potential value in treatment of AMD through enhanced RPE . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.